Currently, GeneDx Holdings Corp [WGS] is trading at $42.44, down -0.82%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The WGS shares have gain 5.76% over the last week, with a monthly amount glided 30.67%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on August 28, 2024, when Wells Fargo initiated its Equal Weight rating and assigned the stock a price target of $34. Previously, Craig Hallum started tracking the stock with Buy rating on July 10, 2024, and set its price target to $43.
This stock has fluctuated between a low of $1.16 and a high of $43.32 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $35.75 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $42.44 at the most recent close of the market. An investor can expect a potential drop of -15.76% based on the average WGS price forecast.
Analyzing the WGS fundamentals
Trailing Twelve Months sales for GeneDx Holdings Corp [NASDAQ:WGS] were 243.66M which represents 44.77% growth. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -0.37%, Pretax Profit Margin comes in at -0.49%, and Net Profit Margin reading is -0.48%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.53 and Total Capital is -0.28. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 41.66 points at the first support level, and at 40.88 for the second support level. However, for the 1st resistance point, the stock is sitting at 43.60, and for the 2nd resistance point, it is at 44.76.
Ratios To Look Out For
To put it in perspective, the Current Ratio for GeneDx Holdings Corp [NASDAQ:WGS] is 2.38. As well, the Quick Ratio is 2.22, while the Cash Ratio is 0.82. Considering the valuation of this stock, the price to sales ratio is 4.69, the price to book ratio is 5.89.
Transactions by insiders
Recent insider trading involved OPKO HEALTH, INC., 10% Owner, that happened on Sep 17 ’24 when 13404.0 shares were purchased. Chief Executive Officer, Stueland Katherine completed a deal on Sep 16 ’24 to sell 10501.0 shares. Meanwhile, CHIEF FINANCIAL OFFICER Feeley Kevin sold 2635.0 shares on Sep 16 ’24.
